期刊文献+

多发性骨髓瘤疼痛分析及治疗 被引量:2

Analysis of Multiple Myeloma Pain and Its Treatment
下载PDF
导出
摘要 目的总结多发性骨髓瘤(MM)的疼痛原因,探索最佳治疗方法。方法对76例骨髓瘤患者进行回顾性分析,患者均伴有中重度骨骼疼痛,按照不同的治疗方法分为4组,比较4组的疗效。结果A组26例,骨痛完全缓解8例,部分缓解13例,无效5例;B组20例,骨痛完全缓解3例,部分缓解5例,无效12例;C组10例,骨痛完全缓解2例,部分缓解3例,无效5例;D组20例,骨痛完全缓解10例,部分缓解7例,无效3例,4种治疗方法的疗效间差异有统计学意义(P<0.05)。骨骼疼痛程度与瘤细胞数、血钙水平呈正相关(P<0.05),与免疫分型无相关性(P>0.05)。结论骨髓瘤患者骨骼疼痛程度与血钙水平及瘤细胞数相关,与免疫分型无关;化疗+膦酸盐+美施康定止痛效果优于单纯化疗。 Objective To analyze the causes of multiple myeloma(MM) pain to find its best remedy.Methods Retrospective analyses were performed on data of 76 MM patients with moderate or severe bone pains,who were divided into 4 groups according to different treatments.The curative effects of 4 groups were compared.Results In group A(n=26),bone pains were completely remitted in 8,partly in 13,no effects in 5;in group B(n=20),completely in 3,partly in 5,no effects in 12;in group C(n=10),completely in 2,partly in 3,no effects in 5;in group D(n=20),completely in 10,partly in 7,no effects in 3,and the difference was significant(P<0.05).Bone pains were positively correlated with oncocyte number and serum calcium level(P<0.05),but not with immunophenotyping(P>0.05).Conclusion Bone pains have correlation with serum calcium level and oncocyte number,but not with immunophenotyping;the effect of chemotherapy plus diphosphonates and MS Contin is superior to chemotherapy alone.
出处 《中国全科医学》 CAS CSCD 北大核心 2009年第14期1323-1324,共2页 Chinese General Practice
关键词 多发性骨髓瘤 疼痛 二膦酸盐类 Multiple myeloma Pain Diphosphonates
  • 相关文献

参考文献10

  • 1[2]Deschamps M,Band PR,Coldman AJ,et al.Assessment of adult cancer pain:Shortcomings of current methods[J].Pain,1988,32(2):133-139.
  • 2董作仁,姚丽.多发性骨髓瘤的临床表现与诊断思维提示[J].中国全科医学,2007,10(18):1497-1498. 被引量:15
  • 3付蓉,邵宗鸿.多发性骨髓瘤骨病病理机制研究进展[J].中华血液学杂志,2004,25(2):125-127. 被引量:16
  • 4李勇华,侯健.多发性骨髓瘤的发病机制[J].中国全科医学,2007,10(18):1492-1495. 被引量:17
  • 5史春雷,王玲,尹刚,袁成录.唑来膦酸联合化疗对多发性骨髓瘤病人骨痛的治疗效果[J].齐鲁医学杂志,2006,21(1):41-42. 被引量:4
  • 6[7]Chang JT,Green L,Beitz J.Renal failure with the use of zoledronic acid[J].N EngL J Med,2003,349(17):1676.
  • 7[8]Crou CP,Jagdev S,Coleman R.The anti -tumor potential of zoledronic acid[J].Breast,2003,12(Suppl 2):s30-s36.
  • 8[9]Jantunen E.Bisphosphonate therapy in multiple myeloma:past,present,future[J].Eur J Haematol,2002,69(5-6):257-264.
  • 9[10]Ross JR,Saunders Y,Edmonds PM,et al.A systematic review of the role of bisphosphonates in metastatic disease[J].Health Technol Assess,2004,8(4):1-176.
  • 10[11]Mccloskey EV,Maclennan IC,Drayson MT,et al.A randomized trial of the effect of clodronate on skeletal monbidity in multiple myeloma.MRC working party on leukaemia in adult[J].Br J Haematol,1998,100(2):317-325.

二级参考文献36

  • 1张天弼,廖建军.多发性骨髓瘤117例分析[J].中国基层医药,2006,13(6):1018-1019. 被引量:5
  • 2REINHOLZ G G,GETZ B,PEDERSON L,et al.Bisphosphonates directly regulate cell prediferation,differentiation,and gene expression in human osteoblasts[J].Cancer Res,2000,60 (21):6001.
  • 3DUNFORD J E,THOMSPON K,COXON F P,et al.Structure activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing hisphosphonates[J].J Pharmacol Exp Ther,2001,296 (2):235.
  • 4CHANG J T,GREEN L,BEITZ J.Renal failure with the use of zoledronic acid[J].N Engl J Med,2003,349(17):1676.
  • 5CROUCHER P,JAGDEV S,COLEMAN R.The anti-tumor potential of zoledronic acid[J].Breast,2003,12 (Suppl 2):930.
  • 6Higgins MJ,Fonseca R.Genetics of multiple myeloma[J].Best Pract Res Clin Haematol,2005,18:525-536.
  • 7Hideshima T,Bergsagel PL,Kuehl WM,et al.Advances in biology of multiple myeloma:clinical applications[J].Blood,2004,104:607-18.
  • 8Fonseca R,Barlogie B,Bataille R,et al.Genetics and cytogenetics of multiple myeloma:a workshop report[J].Cancer Res,2004,64:1546-1558.
  • 9Bergsagel PL,Kuehl WM.Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma[J].Immunol Rev,2003,194:96-104.
  • 10Orlowski RZ.Initial therapy of multiple myeloma patients who are not candidates for stem cell transplantation[J].Hematology Am Soc Hematol Educ Program,2006:338-347.

共引文献45

同被引文献17

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部